Oncologic TherapiesEverett E. Vokes, Harvey M. Golomb Springer Science & Business Media, 21 Kas 2002 - 659 sayfa Our goal for this second edition of Oncologic Therapies is to again provide a brief introduction to the principles and practice of oncology and to oncologic therapies. The book provides a - scription of the major treatment modalities including surgery, radiation therapy, and systemic therapies including classic chemotherapy and biological therapies as well as a brief ov- view of supportive care and quality of life assessments. This is followed by a discussion of site-specific cancers covering the hematologic malignancies and solid tumors. Each chapter is designed to provide a brief discussion of background infor- tion including epidemiology,risk factors,and staging principles followed by a description of standard therapies according to stage as well as current investigational approaches. While the major pathological and clinical features of each disease are d- cussed,the emphasis of this book is clearly on the state of the art of standard and investigational therapies for each tumor type. As such,this book should be useful to general internists with an interest in oncology as well as housestaff and junior oncologists of all major oncologic modalities seeking a brief and focused patient management resource. References providing more - depth discussion for each field are also provided. We rec- mend that any information pertaining to specific chemotherapy regimens and dosing be confirmed in a primary reference since we cannot exclude the possibility of an occasional typograp- cal error. |
İçindekiler
Principles of Surgical Oncology | 3 |
Principles of Radiation Oncology | 9 |
Principles of Cancer Chemotherapy | 19 |
Principles of Cancer Chemoprevention | 67 |
Principles of Cancer Immunotherapy | 79 |
Ethics and the Development of New Oncologic Therapies Informed Consent Equipoise and the Randomized Trial | 95 |
103 | |
Diagnosis and Management of Oncologic Emergencies | 105 |
Breast Cancer | 329 |
Locally Advanced Locally Recurrent and Metastatic Breast Cancer | 341 |
Tumors of the Head and Neck | 355 |
Carcinoma of the Esphogus | 373 |
Lung Cancer | 387 |
Small Cell Lung Cancer | 405 |
Mesothelioma | 413 |
Mesothelioma | 423 |
Infectious Complications of Oncologic Therapy | 115 |
Hematopoietic Growth Factors | 125 |
Pain Management | 139 |
ChemotherapyInduced Nausea and Vomiting | 149 |
Pleural Effusions | 163 |
Measuring Quality of Life | 171 |
181 | |
Acute Leukemia | 183 |
Chronic Myelogenous Leukemia | 211 |
Chronic Lymphocytic Leukemia | 229 |
Myelodysplastic Syndromes | 241 |
Myeloproliferative Disorders | 253 |
Hairy Cell Leukemia | 261 |
Hodgkins Lymphoma | 267 |
Cutaneous T Cell Lymphomas | 281 |
NonHodgkins Lymphoma | 293 |
Multiple Myeloma and Other Plasma Cell Dyscrasias | 317 |
327 | |
Colorectal Cancer | 437 |
Anal Cancers | 449 |
Gastric Cancer 33 Gastric Cancer | 459 |
Hepatobillary Cancer | 487 |
Testicular Cancer | 497 |
Renal Cancer | 511 |
Genitourinary Malignancies BladderPenisUrethral Cancers | 519 |
Gynecologic Cancers | 529 |
Cervical Vulvar and Vaginal Cancer | 543 |
Ovarian Cancer | 561 |
Brain Tumors | 567 |
Sarcomas | 585 |
SoftTissue Sarcomas | 595 |
Thyroid Malignancies | 607 |
Skin Cancers | 625 |
NonMelanoma Skin Neoplasms | 641 |
Subject Index | 647 |
Diğer baskılar - Tümünü görüntüle
Sık kullanılan terimler ve kelime öbekleri
5-fluorouracil activity acute adjuvant agents antigen biopsy Blood bone marrow breast cancer cancer patients carboplatin cell carcinoma chemo chemother chemotherapy chronic cisplatin clinical trials colorectal combination cyclophosphamide cytarabine cytogenetic cytotoxic diagnosis dose doxorubicin drug effects emesis Engl etoposide evaluation G-CSF gemcitabine gene growth factor Gynecol head and neck high-dose histologic Hodgkin's IFN-a ifosfamide Int J Radiat invasive involvement lesions leukemia liver lung cancer lymph node lymphocytic lymphoma malignant pleural melanoma ment mesothelioma metastatic metastatic disease methotrexate mg/m² modality myeloid myelosuppression Oncology Group overall survival paclitaxel pelvic phase II study phase II trial pleural effusions Proc Am Soc prognostic prostate cancer radiation therapy radiotherapy randomized trial receptor recurrence regimens relapse remission renal resection response rate sarcoma Soc Clin Oncol squamous cell stage stem cell surgery surgical syndrome Table tamoxifen thyroid tients tion tissue toxicity transplantation treated treatment versus